S. Alonso

1.0k total citations
14 papers, 601 citations indexed

About

S. Alonso is a scholar working on Oncology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, S. Alonso has authored 14 papers receiving a total of 601 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Oncology, 4 papers in Surgery and 4 papers in Pulmonary and Respiratory Medicine. Recurrent topics in S. Alonso's work include Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Neutropenia and Cancer Infections (2 papers). S. Alonso is often cited by papers focused on Cancer Treatment and Pharmacology (5 papers), Colorectal Cancer Treatments and Studies (4 papers) and Neutropenia and Cancer Infections (2 papers). S. Alonso collaborates with scholars based in Spain, Italy and Lebanon. S. Alonso's co-authors include Ricardo Hitt, H. Cortés-Funes, Cristina Grávalos, Manuel Hidalgo, Daniel Castellano, Luis Paz‐Ares, Rámón Colomer, Aňa Lluch, B. Ojeda and P. Lianes and has published in prestigious journals such as Journal of Clinical Oncology, SHILAP Revista de lepidopterología and JNCI Journal of the National Cancer Institute.

In The Last Decade

S. Alonso

14 papers receiving 579 citations

Peers

S. Alonso

ONCOL

SURGE

PRM

L. Iglesias Spain

P H de Mulder Netherlands

J.J. Lafitte France

Lyndah Dreiling United States

P. Comella Italy

Anna Cariello Italy

Florence Cheung China

Carlo Alberto Giorgi Italy

Shamayel Mohammed Saudi Arabia

Yabing Cao China

L. Iglesias Spain

S. Alonso

408 ×0.9

ONCOL

149 ×1.1

96 ×0.8

SURGE

210 ×1.8

PRM

157 ×1.6

Citations per year, relative to S. Alonso S. Alonso (= 1×) peers L. Iglesias

Countries citing papers authored by S. Alonso

Since Specialization

Citations

This map shows the geographic impact of S. Alonso's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by S. Alonso with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites S. Alonso more than expected).

Fields of papers citing papers by S. Alonso

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by S. Alonso. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by S. Alonso. The network helps show where S. Alonso may publish in the future.

Co-authorship network of co-authors of S. Alonso

This figure shows the co-authorship network connecting the top 25 collaborators of S. Alonso. A scholar is included among the top collaborators of S. Alonso based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with S. Alonso. S. Alonso is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

Ramia, José Manuel, et al.. (2016). Gallbladder spindle and giant cell type undifferentiated carcinoma and cholecysto-colonic fistula. HPB. 18. e478–e478. 1 indexed citations

Paola, Eugenio Donato Di, S. Alonso, Rosa Giuliani, et al.. (2012). An open-label, dose-finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors. SHILAP Revista de lepidopterología. 2. 175–175. 2 indexed citations

Mancuso, Andrea, Eugenio Donato Di Paola, Alvaro Leone, et al.. (2011). Phase II escalation study of sorafenib in patients with metastatic renal cell carcinoma who have been previously treated with anti‐angiogenic treatment. British Journal of Urology. 109(2). 200–206. 22 indexed citations

Calabrò, Fabio, Vito Lorusso, Gerardo Rosati, et al.. (2009). Gemcitabine and paclitaxel every 2 weeks in patients with previously untreated urothelial carcinoma. Cancer. 115(12). 2652–2659. 72 indexed citations

Paola, Eugenio Donato Di, S. Alonso, Rosa Giuliani, et al.. (2009). Dose finding study of the combination of satraplatin and gemcitabine in patients with advanced solid tumors. Journal of Clinical Oncology. 27(15_suppl). e13534–e13534. 2 indexed citations

Guijarro, María V., Juan Fernando Martínez-Leal, Carmen Blanco‐Aparicio, et al.. (2007). MAP17 enhances the malignant behavior of tumor cells through ROS increase. Carcinogenesis. 28(10). 2096–2104. 53 indexed citations

Calabrò, Fabio, C. Sternberg, Teodoro Sava, et al.. (2005). Multicenter phase II study of every-2 week gemcitabine and paclitaxel as first-line chemotherapy in patients with advanced urothelial tract cancer. Journal of Clinical Oncology. 23(16_suppl). 4583–4583. 2 indexed citations

Colomer, Rámón, Antonio Llombart‐Cussac, Aňa Lluch, et al.. (2004). Biweekly paclitaxel plus gemcitabine in advanced breast cancer: phase II trial and predictive value of HER2 extracellular domain. Annals of Oncology. 15(2). 201–206. 79 indexed citations

Vega, Fernando Arias de la, et al.. (2003). Hyperfractionated Radiotherapy and Concomitant Cisplatin for Locally Advanced Laryngeal and Hypopharyngeal Carcinomas. American Journal of Clinical Oncology. 26(6). 550–557. 8 indexed citations

10.

Hornedo, Javier, C. Solà, Carlos Solano, et al.. (2002). The role of granulocyte colony-stimulating factor (G-CSF) in the post-transplant period. Bone Marrow Transplantation. 29(9). 737–743. 35 indexed citations

11.

Colomer, Rámón, Antonio Llombart‐Cussac, Aňa Lluch, et al.. (2000). Paclitaxel/gemcitabine administered every two weeks in advanced breast cancer: preliminary results of a phase II trial.. PubMed. 27(1 Suppl 2). 20–4. 29 indexed citations

12.

Hasbini, Ali, Abderrahim Fandi, Nadia Chouaki, et al.. (1999). Phase II trial combining mitomycin with 5-fluorouracil, epirubicin, and cisplatin in recurrent and metastatic undifferentiated carcinoma of nasopharyngealtype. Annals of Oncology. 10(4). 421–425. 42 indexed citations

13.

Hidalgo, Manuel, Daniel Castellano, Luis Paz‐Ares, et al.. (1999). Phase I-II Study of Gemcitabine and Fluorouracil as a Continuous Infusion in Patients With Pancreatic Cancer. Journal of Clinical Oncology. 17(2). 585–585. 154 indexed citations

14.

Mayordomo, José, Fernando Rivera, P. Lianes, et al.. (1995). Improving Treatment of Chemotherapy-Induced Neutropenic Fever by Administration of Colony-Stimulating Factors. JNCI Journal of the National Cancer Institute. 87(11). 803–808. 100 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact